Literature DB >> 12646812

Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission.

Sibyl Geelen, Joep Lange, Jan Borleffs, Tom Wolfs, Annemarie Weersink, Rob Schuurman.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12646812     DOI: 10.1097/00002030-200303280-00027

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

1.  Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.

Authors:  Sihong Xu; Aijing Song; Jianhui Nie; Xiuhua Li; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2010-10-01       Impact factor: 4.074

2.  An avoidable transmission of HIV from mother to child.

Authors:  Tyler O'Bryan; Taj Jadavji; John Kim; M John Gill
Journal:  CMAJ       Date:  2010-11-22       Impact factor: 8.262

3.  Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.

Authors:  Peilin Li; Theodore Ruel; Katsuya Fujimoto; Hiroyu Hatano; Steven Yukl; Leigh Anne Eller; Teri Liegler; Moses Kamya; Anne Gassasira; Grant Dorsey; Philip J Rosenthal; Diane V Havlir; Joseph K Wong
Journal:  J Virol Methods       Date:  2010-09-21       Impact factor: 2.014

4.  Evaluation of the Abbott investigational use only realtime HIV-1 assay and comparison to the Roche Amplicor HIV-1 monitor test, version 1.5.

Authors:  Michael T Pyne; Eric Q Konnick; Amit Phansalkar; David R Hillyard
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

5.  Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.

Authors:  Priscilla Swanson; Carmen de Mendoza; Yagnya Joshi; Alan Golden; Richard L Hodinka; Vincent Soriano; Sushil G Devare; John Hackett
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.

Authors:  Michael T Pyne; Katherine L Brown; David R Hillyard
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

7.  Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.

Authors:  Africa Holguín; Marisa López; Mar Molinero; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

8.  Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.

Authors:  John A Crump; Lesley E Scott; Emma Msuya; Anne B Morrissey; Ekyafyose E Kimaro; John F Shao; Wendy S Stevens
Journal:  J Virol Methods       Date:  2009-09-01       Impact factor: 2.014

9.  The challenge of HIV-1 genetic diversity: discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain.

Authors:  Hector Bolivar; Rebeca Geffin; Gabriel Manzi; Margaret A Fischl; Vera Holzmayer; Wai-Bing Mak; Klara Abravaya; John Hackett
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.771

10.  Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.

Authors:  Beatriz de Felipe; Pilar Pérez-Romero; María Abad-Fernández; Felipe Fernandez-Cuenca; Francisco J Martinez-Fernandez; Mónica Trastoy; Rosario Del Carmen Mata; Luis F López-Cortés; Manuel Leal; Pompeyo Viciana; Alejandro Vallejo
Journal:  Virol J       Date:  2011-08-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.